Summary & Overview
HCPCS J7070: Infusion, D5W, 1000 cc
HCPCS Level II code J7070 denotes infusion of dextrose 5% in water (D5W), 1000 cc, a commonly used large-volume crystalloid for fluid maintenance and replacement. Nationally, billing and coverage for intravenous fluids like D5W affect acute care settings, emergency departments, infusion centers, and hospital outpatient services where IV fluid administration is routine. This code matters for facility billing, inventory management, and claims processing because it identifies a specific supply/infusion commodity rather than a procedure-based service.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find coverage and billing context for payers commonly used in national analyses, along with typical sites of service and clinical context for use of D5W 1000 cc. The publication provides benchmarks for coding and billing practice, summaries of payer policy approaches where available, and notes on common administrative considerations that affect claim submission and reimbursement processing.
Data not available in the input is noted where payer-specific policy details, associated taxonomies, and ICD-10 linkage would normally appear.
Billing Code Overview
HCPCS Level II code J7070 represents infusion of dextrose 5% in water (D5W), 1000 cc. The service is an infusion/IV fluid administration typically provided when large-volume crystalloid replacement or maintenance fluids are required.
Service Type: Infusion/IV fluid therapy
Typical Site of Service: Hospital inpatient, hospital outpatient, emergency department, and infusion centers where intravenous fluid administration is performed. If outpatient or clinic details are required, Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old adult presents to an outpatient infusion center for administration of J7070 (Infusion, D5W, 1000 cc). The patient has moderate dehydration after a gastrointestinal illness with persistent vomiting and is being treated for volume repletion and electrolyte stabilization. The clinical workflow begins with triage and vital signs in the infusion suite, assessment by the infusion nurse and supervising clinician (e.g., hospitalist, emergency physician, or ambulatory infusion specialist), establishment of peripheral IV access, and verification of orders and allergies. The D5W 1000 cc bag is prepared and labeled, infusion pump settings are programmed per the clinician’s orders, and the infusion is initiated with monitoring for tolerance, fluid overload, and adverse reactions. Documentation includes start and stop times, volume infused, patient response, IV site checks, and any interventions. At completion, discharge instructions and follow-up are provided, and billing is submitted with J7070 and any applicable service or facility modifiers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management (E/M) service by the same physician on the day of a procedure |